MedPath

Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of Left Main Coronary Artery Stenosis

Recruiting
Conditions
Left Main Coronary Artery Disease
Registration Number
NCT06053944
Lead Sponsor
China National Center for Cardiovascular Diseases
Brief Summary

This is a prospective, observational, single-center study. The main purpose of this study is to evaluate the diagnostic accuracy of offline computational ultrasonic flow ratio (UFR) in predicting functionally significant left main (LM) coronary stenosis with conventional pressure wire-based fractional flow reserve (FFR) as the standard reference. The study will be conducted in Fuwai Hospital, and a total of 120 patients with intermediated left main coronary vessel diameter stenosis ≥30% and ≤80% are planned to be recruited. Participants who meet the inclusion criteria and do not meet the exclusion criteria will undergo intravascular ultrasound (IVUS) followed by FFR examination. IVUS imaging will be sent to an independent core laboratory for UFR calculation. UFR analyses were performed offline in a blinded fashion without awareness of FFR measurement. Using FFR≤0.80 as the gold standard, the sensitivity and specificity of UFR in the functional significance of left main coronary artery stenosis will be analyzed.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Stable angina pectoris, unstable angina pectoris, or after the acute phase of myocardial infarction
  • Age ≥18 years
  • Written informed consent
  • Intermediated left main coronary lesions (diameter stenosis of 30%-80% by visual estimation from coronary angiography)
Exclusion Criteria
  • Ineligible for diagnostic IVUS or FFR examination
  • Prior coronary artery bypass grafting of the interrogated vessels
  • Myocardial infarction within 72 h of coronary angiography
  • Severe heart failure
  • Serum creatinine levels >150 umol/L, or glomerular filtration rates <45 ml/ kg/1.73 m2
  • Allergy to the contrast agent or adenosine
  • Life expectancy < 2 years
  • Proximal LAD diffuse lesions (diameter stenosis > 50%)
  • IVUS pullback not covering the entire lesion
  • Severe myocardial bridge in the interrogated vessel

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic accuracy of UFR in predicting functionally significant left main coronary stenosis, using FFR as the reference standardImmediately after the procedure

Diagnostic accuracy is defined as UFFR (≤0.80 or \>0.80) to identify hemodynamically-significant left main coronary stenosis with FFR (≤0.80 or \>0.80) as the reference standard.

Sensitivity and specificity of UFR in predicting functionally significant left main coronary stenosis, using FFR as the reference standardImmediately after the procedure

Sensitivity is defined as the proportion of UFR ≤ 0.80 in vessels with hemodynamically-significant stenosis as measured by FFR (FFR ≤ 0.80); specificity is defined as the proportion of UFR \> 0.80 in vessels without hemodynamically-significant stenosis as measured by FFR (FFR \> 0.80).

Secondary Outcome Measures
NameTimeMethod
The AUC of UFR for left main coronary stenosis with FFR as the gold standardImmediately after the procedure

AUC is defined as the area under the receiver-operating characteristic curve.

Comparison of sensitivity and specificity of UFR and IVUS-derived minimal lumen area (MLA) in predicting functionally significant left main coronary stenosis, using FFR as the reference standardImmediately after the procedure

Sensitivity is defined as the proportion of UFR ≤ 0.80 in vessels with hemodynamically-significant stenosis as measured by FFR (FFR ≤ 0.80); specificity is defined as the proportion of UFR \> 0.80 in vessels without hemodynamically-significant stenosis as measured by FFR (FFR \> 0.80).

Trial Locations

Locations (1)

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

🇨🇳

Beijing, Select A State, China

© Copyright 2025. All Rights Reserved by MedPath